Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

Aromatase inhibitors can cause various adverse reactions, so monitoring is crucial.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Atorvastatin is less effective for women with Hashimoto's thyroiditis.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Drugs for prostate enlargement and hair loss were not linked to increased risk of depression or suicide.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

The new system greatly improves carvedilol's solubility and effectiveness.

JAK inhibitors show promise for treating various skin diseases.

*Acorus calamus* has many medicinal benefits but needs more safety research.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Adalimumab can cause complete hair loss in rare cases.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Afatinib often causes skin problems that need proactive management.

Tofacitinib taken by mouth helps treat hair loss in children.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

Low education and income can lead to not following high blood pressure treatment.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.